Senti Bio appoints Fran Schulz to board of directors

Senti Bio (SNTI)sciences has appointed Fran Schulz to the Senti Bio Board of Directors. Concurrently with Ms. Schulz’s appointment to the Board, she will serve as the chairperson of the Board’s Audit Committee. In conjunction with Ms. Schulz’s appointment, Dr. Omid Farokhzad is departing from the Board. The Company thanks Dr. Farokhzad for his years of service as a director. Ms. Schulz was one of the founding members and senior partners in Ernst & Young’s (“EY”) Life Sciences Practice and has held various roles at EY over 35 years.